BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//MLSC - ECPv6.15.18//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:MLSC
X-ORIGINAL-URL:https://www.masslifesciences.com
X-WR-CALDESC:Events for MLSC
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20200308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20201101T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20210314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20211107T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20220313T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20221106T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20211012T100000
DTEND;TZID=America/New_York:20211013T160000
DTSTAMP:20260413T083322
CREATED:20210908T202238Z
LAST-MODIFIED:20210908T202238Z
UID:14592-1634032800-1634140800@www.masslifesciences.com
SUMMARY:2021 Global Conference on Regulatory Science: Digital Health and Medical Devices
DESCRIPTION:Join us at the “2021 Global Conference on Regulatory Science\,” hosted virtually on October 12-13 by the Harvard-MIT Center for Regulatory Science. This year’s theme of “Digital Health and Medical Devices\,” will address the challenges and opportunities for harnessing digitally enabled technologies in support of optimal patient health outcomes. \nThe conference will include plenary presentations and panel discussions on day one and multi-stakeholder working group sessions on day two. Topics featured at the conference will include:\n• International approaches to device regulation\n• Challenges and opportunities in pediatric device development\n• Pfizer’s implementation of decentralized clinical trials\n• Development of a post-market surveillance network for medical devices\n• Digital innovations in the mental health space \nLearn more and register at https://hmcrs.org/event/global-conference/ \nWe hope to see you there!\nHarvard-MIT CRS
URL:https://www.masslifesciences.com/event/2021-global-conference-on-regulatory-science-digital-health-and-medical-devices/
LOCATION:Virtual Event
ORGANIZER;CN="Harvard-MIT Center for Regulatory Science":MAILTO:hits_regsci@harvard.edu
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20211007T090000
DTEND;TZID=America/New_York:20211007T103000
DTSTAMP:20260413T083322
CREATED:20210809T155314Z
LAST-MODIFIED:20210809T155314Z
UID:14428-1633597200-1633602600@www.masslifesciences.com
SUMMARY:Women Who Lead in Life Sciences
DESCRIPTION:A look at the women in the ever-expanding sector of life sciences and biotech. \nHow many women have made it into the C-Suite\, the boardroom\, the labs\, and what does the leadership pipeline look like? \nWe will talk with women in top roles about their personal stories and hear their views on how Life Science and Biotech companies in our region are evolving culture\, policies and programs that will result in more equity and opportunity for women. \nStay Connected and join us for VIRTUAL NETWORKING. Attendees will have the opportunity to connect with others from Boston’s business community! \nSponsored by: Massachusetts Life Sciences Center
URL:https://www.masslifesciences.com/event/women-who-lead-in-life-sciences/
LOCATION:Online\, online
ORGANIZER;CN="Boston Business Journal":MAILTO:boston@bizjournals.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20211006T183000
DTEND;TZID=America/New_York:20211006T193000
DTSTAMP:20260413T083322
CREATED:20211004T130304Z
LAST-MODIFIED:20211004T130304Z
UID:14613-1633545000-1633548600@www.masslifesciences.com
SUMMARY:with/in/sight webinar: Oxygenating the Pipeline
DESCRIPTION:This evening webinar profiles the bench to bedside progress of the Cima Lab’s efforts targeting tumor oxygen levels as a vulnerability in cancer. Through innovative prototyping and clinical trials\, researchers have developed a responsive sensor to sample and relay information about oxygen levels that can inform treatment decisions to dramatically affect how tumors respond to radiation therapy. Discover the ins and out of personalized treatment and learn how the team is drawing on resources across the research spectrum to improve cancer treatment and patient outcomes.
URL:https://www.masslifesciences.com/event/with-in-sight-webinar-oxygenating-the-pipeline/
LOCATION:Virtual Event
ORGANIZER;CN="Koch Institute for Integrative Cancer Research at MIT":MAILTO:kievents@mit.edu
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20211006T120000
DTEND;TZID=America/New_York:20211006T130000
DTSTAMP:20260413T083322
CREATED:20211004T125822Z
LAST-MODIFIED:20211004T125847Z
UID:14630-1633521600-1633525200@www.masslifesciences.com
SUMMARY:Introduction to Medical Device Human Factors
DESCRIPTION:M2D2’s “Introduction to Medical Device Human Factors” will introduce and define what exactly “human factors” are and how they relate to the making of medical devices.\nSome of the topics that will be covered:\nHuman factors engineering\nHuman factors standards and guidance\nThe HF/UE process\nRisk analysis\nUser interfaces\nMany more topics to be discussed! \nBeth Loring\, MS\, CHFP\nFounder & Principal
URL:https://www.masslifesciences.com/event/introduction-to-medical-device-human-factors/
LOCATION:MA
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210930T120000
DTEND;TZID=America/New_York:20210930T130000
DTSTAMP:20260413T083322
CREATED:20210805T225829Z
LAST-MODIFIED:20210805T225829Z
UID:14392-1633003200-1633006800@www.masslifesciences.com
SUMMARY:Grant Writing Workshop:  Non-dilutive grant funding for early-stage technology companies
DESCRIPTION:Attend for an overview of SBIR/STTR programs relating to biomedical and medical device technologies with a focus on NIH and NSF. \nAbout this event: \nAttend to hear Natalie Rudolph go over the following topics: \n• Overview of SBIR/STTR programs relating to biomedical and medical device technologies\,\nwith a focus on NIH and NSF \n• Essential elements of a successful SBIR/STTR project \n• Key components of a competitive SBIR/STTR application \nNatalie will also be hosting 1:1 meetings from 1pm – 3pm for those who are interested in connecting with her further. If you’re interested in scheduling time with her please send us an email at M2D2@uml.edu. \nNatalie S. Rudolph\, Ph.D. \nRudolph Biomedical Consulting \nRudolph Biomedical Consulting works with early-stage technology companies to identify potential non-dilutive funding sources\, design R&D projects\, and write grant applications to fund them. Project areas include biotechnology\, medical devices and telehealth. My focus is Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) grants and contracts from NIH\, NSF and DOD. However\, my work spans a wide range of opportunities from agencies such as BARDA\, DARPA\, NIH\, NSF\, DoD\, AHRQ and PCORI. My clients include small companies and academic investigators\, and institutions preparing large complex program proposals. \nMy projects begin with a planning exercise to define the goals and deliverables and to outline the proposed work. This allows us to determine the best match with the funding opportunity objectives\, scope\, budget and duration. \nI love working with the energy and enthusiasm of entrepreneurs!
URL:https://www.masslifesciences.com/event/grant-writing-workshop-non-dilutive-grant-funding-for-early-stage-technology-companies/
LOCATION:Virtual Event
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210930T120000
DTEND;TZID=America/New_York:20210930T124500
DTSTAMP:20260413T083322
CREATED:20210819T171924Z
LAST-MODIFIED:20210819T171924Z
UID:14468-1633003200-1633005900@www.masslifesciences.com
SUMMARY:The Healing Power of Patient Stories
DESCRIPTION:In this Harvard Medical School Executive Education webinar\, Annie Brewster\, MD will discuss the transformational power of sharing patient voices and stories. A new diagnosis is just the starting point. The patient will then begin their journey of integrating this diagnosis into their life\, into their relationships and their identity. Brewster will discuss the power of patient stories and how they can improve health care and spur innovations that meet patient needs.
URL:https://www.masslifesciences.com/event/the-healing-power-of-patient-stories/
LOCATION:Online\, online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210929T163000
DTEND;TZID=America/New_York:20210929T193000
DTSTAMP:20260413T083322
CREATED:20210908T202257Z
LAST-MODIFIED:20210908T202257Z
UID:14577-1632933000-1632943800@www.masslifesciences.com
SUMMARY:Fall MetroWest Life Science Mixer
DESCRIPTION:Come join BioXchange and the MetroWest Life Science Network for a chance to meet people from not only the Boston/ Cambridge life science ecosystem\, but get the chance to expand your life science network in the MetroWest area! Bring your vaccine card and a mask and enjoy some great local food and enjoy a drink on a beautiful fall day at ABI-Lab right in Natick\, MA. This event will be indoor/outdoor to fit everyone’s comfort zones. We hope to see you there! \nThe event is being sponsored by Elemental Machines\, ABI-LAB\, ThermoFisher Scientific\, McDermott Will & Emery\, and DENS Facility Services. Food sponsors include Lookout Farm and Verve Hotel Natick. \nABI-Lab is requiring all guests/visitors/delivery persons to wear masks and for the September 29th event. All attendees MUST be vaccinated and show proof of vaccination at registration. Either with a physical vaccine card\, or via a mobile record. They feel this is the best solution to ensure attendants of the event are safe.\nNO FOOD OR DRINK INSIDE\nMASKS REQUIRED INSIDE\nNO ONE WILL BE ALLOWED AT THE EVENT WITHOUT PROOF OF VACCINATION
URL:https://www.masslifesciences.com/event/fall-metrowest-life-science-mixer/
LOCATION:ABI-LAB\, 22 Strathmore Road\, Natick\, MA\, United States
ORGANIZER;CN="BioXchange":MAILTO:bioxchange.boston@gmail.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210928
DTEND;VALUE=DATE:20211008
DTSTAMP:20260413T083322
CREATED:20210802T155122Z
LAST-MODIFIED:20210802T155122Z
UID:14323-1632787200-1633651199@www.masslifesciences.com
SUMMARY:Designing and Implementing AI Solutions for Health Care
DESCRIPTION:Applications of artificial intelligence in health care are expanding rapidly. Despite its great long-term potential\, risks and challenges remain for both AI developers and their partners in health care\, the life sciences industry and digital health. \nThis Harvard Medical School Executive Education program will allow leaders across the ecosystem to gain insights into what it takes to successfully utilize AI in the unique cultural\, economic and regulatory context of health care. Interactive sessions will address technical concepts as well as real-world implementation\, with examples drawn from health care delivery/operations and drug development. \nThe curriculum will feature a combination of live virtual class sessions\, small group application exercises\, pre-work and vigorous discussions. Upon completion of the program\, participants will be able to immediately apply insights gained to the fast-moving and complex health care sector. A certificate of completion will be provided.
URL:https://www.masslifesciences.com/event/designing-and-implementing-ai-solutions-for-health-care-2/
LOCATION:Online\, online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210923T103000
DTEND;TZID=America/New_York:20210923T113000
DTSTAMP:20260413T083322
CREATED:20210802T155845Z
LAST-MODIFIED:20210802T155845Z
UID:14380-1632393000-1632396600@www.masslifesciences.com
SUMMARY:Life Sciences Apprenticeship Launch
DESCRIPTION:Join us to celebrate the launch of the first Life Sciences Apprenticeship Program in Massachusetts\, providing candidates an alternative pathway to careers in biomanufacturing and clinical trials. This community event will introduce the first two cohorts of apprentices and highlight participating employers. We will also hear from key public officials committed to workforce development initiatives\, locally to nation wide. \nHonorary Remarks By:\nUnited States Secretary of Labor Marty Walsh\nMassachusetts Secretary of Labor and Workforce Development Rosalin Acosta\nRepresentative Lori Trahan\, Third District of Massachusetts \nGuest Remarks By:\nKenn Turner\, President and CEO\, Massachusetts Life Sciences Center\nKendalle Burlin O’Connell\, President and COO\, MassBio\nEmployer Partner – Bristol Myers Squibb\n2021 Apprentice Class Member \nAbout the Program\nThis unique program is registered with the state as an apprenticeship and provides candidates an alternative pathway into the life sciences industry. MassBioEd has focused on recruiting candidates from under-represented groups in the industry as well as unemployed and under-employed individuals. Through accelerated training\, apprentices will gain foundational knowledge\, industry-recognized skills\, and work experience\, providing them with career opportunities at sustainable wages. MassBioEd chose to target Biomanufacturing Technicians and Clinical Trial Associates for the first year of the apprenticeship program because of high employer demand for these occupations.
URL:https://www.masslifesciences.com/event/life-sciences-apprenticeship-launch/
LOCATION:Online\, online
ORGANIZER;CN="MassBioEd":MAILTO:communications@massbioed.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210922T160000
DTEND;TZID=America/New_York:20210922T190000
DTSTAMP:20260413T083322
CREATED:20210827T143049Z
LAST-MODIFIED:20210827T143049Z
UID:14527-1632326400-1632337200@www.masslifesciences.com
SUMMARY:Mini Golf for Good
DESCRIPTION:There is NOTHING quite like the Mini Golf for Good Tournament to benefit Life Science Cares! This fun and competitive event features three nine-hole mini-golf courses popping up in the middle of Tech Square\, with company teams putting for a variety of trophies. This party attracts 300+ employees of life science companies to enjoy the food trucks\, free beer\, lawn games\, raffle\, and crazy costumes of their peers. Don’t miss the drama as company teams compete for bragging rights in categories like Most Holes in One\, Best Outfits\, Best Team Names & Worst Score. Learn more and register at https://lifesciencecares.org/events/mini-golf-for-good. \nSeptember 22\, 2021\n4 p.m.-7 p.m.\n*Raindate: September 29\, 2021\nTech Square\, Cambridge
URL:https://www.masslifesciences.com/event/mini-golf-for-good/
LOCATION:MA
ORGANIZER;CN="Life Science Cares":MAILTO:info@lifesciencecares.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210917T083000
DTEND;TZID=America/New_York:20210917T160000
DTSTAMP:20260413T083322
CREATED:20210802T154831Z
LAST-MODIFIED:20210802T154831Z
UID:14361-1631867400-1631894400@www.masslifesciences.com
SUMMARY:Engineering the Next Wave of Immunotherapy
DESCRIPTION:Engineering the Next Wave of Immunotherapy\nFriday\, September 17\, 2021\n8:30 a.m. EDT on Zoom\nThe 19th Annual Koch Institute Summer Symposium will be held virtually on September 17\, 2021 and will focus on cancer immunotherapy. Register now (https://mit.zoom.us/webinar/register/WN_iD8S9uJRQZuzXxZG4Ef9uA). \nCancer immunotherapy has revolutionized the landscape of cancer treatment\, our thinking of tumor biology and clinical practice. Following the groundbreaking successes of checkpoint blockade therapy and CAR T cell therapy\, culminating in multiple FDA-approved treatments and the awarding of the 2018 Nobel Prize in Medicine to Jim Allison and Tasuku Honjo\, the field is currently at a critical juncture. \nWhile checkpoint blockade therapy has demonstrated that the immune system can be harnessed to fight cancer\, the next generation of treatments will require us to understand what causes resistance in non-responders\, how this can be overcome\, and how these issues are best addressed clinically. Discussing these questions will be at the core of this symposium as we move towards our ultimate goal to increase the number of patients benefiting from immunotherapy. \nSpeakers\nTargeting T Cells\nRafi Ahmed\, Michael Dougan\, Chris Love \nThinking Beyond T Cells\nYasmine Belkaid\, Juan Mendoza\, Stefani Spranger\, Lauren Zasadil \nEngineering Clinical Translation\nChris Garcia\, Juliana Idoyaga\, Crystal Mackall \nPanel Discussion: Clinical Translation: A Real Life Perspective\nDaniel Chen\, Michael Dougan\, Kimberly Shafer-Weaver\nModerators: Steven Silverstein\, Jane Wilkinson \nThank You to Our Sponsors\nAgilent Technologies\, Inc.\nDragonfly Therapeutics\, Inc.\nRepertoire Immune Medicines\nRibon Therapeutics\nSkyhawk Therapeutics
URL:https://www.masslifesciences.com/event/engineering-the-next-wave-of-immunotherapy/
LOCATION:Online\, online
ORGANIZER;CN="Koch Institute for Integrative Cancer Research at MIT":MAILTO:kievents@mit.edu
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210915T120000
DTEND;TZID=America/New_York:20210915T133000
DTSTAMP:20260413T083322
CREATED:20210827T142815Z
LAST-MODIFIED:20210827T142815Z
UID:14542-1631707200-1631712600@www.masslifesciences.com
SUMMARY:mRNA: The Future of Therapeutics
DESCRIPTION:2020 was the year that established mRNA as a household name around the globe. This previously unheard-of treatment option suddenly became the poster child as a way to end the COVID-19 pandemic. Both the Pfizer and Moderna COVID-19 vaccines contain mRNA that once injected\, encodes for the spike glycoprotein found on the surface of the virus. Since first discovered in 1961\, mRNA has emerged as a promising therapeutic medication to treat a host of other diseases including cancer\, heart disease\, autoimmune conditions\, and cystic fibrosis. Could the future eradication of such devastating diagnoses be as simple as receiving a unique sequence of nucleotides that encode for a specific protein? Hear from a handful of innovative scientists working at the forefront of developing these potentially life altering medications. \nJoin us for this discussion on the Clubhouse App.
URL:https://www.masslifesciences.com/event/mrna-the-future-of-therapeutics/
LOCATION:France
ORGANIZER;CN="Caldwell Intellectual Property Law":MAILTO:eyob@caldwellip.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210908
DTEND;VALUE=DATE:20210927
DTSTAMP:20260413T083322
CREATED:20210908T201738Z
LAST-MODIFIED:20210908T201738Z
UID:14600-1631059200-1632700799@www.masslifesciences.com
SUMMARY:UMass M2D2 Presents IMPACT: Work 1-on-1 with Investors from Boston Scientific & Asahi Intecc
DESCRIPTION:IMPACT is a 12-week accelerator program for life sciences startups that aims to help advance their innovations. Applications are officially open for Cycle 1 of the IMPACT Accelerator Program!\nAttend educational workshops\nAccess mentorship and resources needed for the commercialization of your idea\nIf your startup is chosen for the Cycle 1 Cohort\, you’ll pitch your solution to a panel of investors with the ability to have 1-on-1 meetings with experts from major corporations like Boston Scientific and Asahi Intecc! \nAPPLY BY SEPTEMBER 26th @ 11:59PM EST!
URL:https://www.masslifesciences.com/event/umass-m2d2-presents-impact-work-1-on-1-with-investors-from-boston-scientific-asahi-intecc/
LOCATION:MA
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210825T160000
DTEND;TZID=America/New_York:20210825T190000
DTSTAMP:20260413T083322
CREATED:20210819T172640Z
LAST-MODIFIED:20210819T172640Z
UID:14411-1629907200-1629918000@www.masslifesciences.com
SUMMARY:Virtual BioXchange
DESCRIPTION:Miss being able to network with colleagues in the life science industry? We have you covered with the best virtual networking experience through Grapevine Network’s networking platform. Connect with life science colleagues from all over the world. \nBioXchange has gone virtual to allow the best online opportunity to interact with individuals from throughout the life science industry. The event will be hosted on Grapevine Network’s platform which provides an amazing experience that allows attendees the freedom to navigate between different group discussions within an interactive chatroom environment. The platform provides the closest experience to a live networking experience. \nParticipants are welcome to join the event at any point of time. The event is subject to run later than the posted end time as the room will stay open as long as people are actively engaged within the chat room. \n***Event is expected to sell out and NOT ALL RVSPS ARE GUARANTEED ENTRY into the event due to the limited attendee capacity offered on the platform.
URL:https://www.masslifesciences.com/event/virtual-bioxchange-5/
LOCATION:Online\, online
ORGANIZER;CN="BioXchange":MAILTO:bioxchange.boston@gmail.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210820T100000
DTEND;TZID=America/New_York:20210820T110000
DTSTAMP:20260413T083322
CREATED:20210809T154041Z
LAST-MODIFIED:20210809T154230Z
UID:14423-1629453600-1629457200@www.masslifesciences.com
SUMMARY:Info Session: Angel Investor Tax Credit Program
DESCRIPTION:Offered to investors interested in funding early-stage companies engaged in life sciences research and development\, commercialization\, and manufacturing in Massachusetts. \nWe are excited to inform you that the MLSC has launched the second round of the Angel Investor Tax Credit program\, which aims to encourage investments in gateway municipalities and throughout the Commonwealth. \nTwo deadlines are offered to apply:\n• October 29\, 2021\n• January 14\, 2022 \nJoin us to learn more about this exciting opportunity!
URL:https://www.masslifesciences.com/event/info-session-angel-investor-tax-credit-program/
LOCATION:Online\, online
ORGANIZER;CN="Institute for Applied Life Sciences":MAILTO:contactials@umass.edu
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210818T120000
DTEND;TZID=America/New_York:20210818T133000
DTSTAMP:20260413T083322
CREATED:20210805T230545Z
LAST-MODIFIED:20210805T231422Z
UID:14397-1629288000-1629293400@www.masslifesciences.com
SUMMARY:Project Onramp Showcase 2021
DESCRIPTION:Project Onramp creates paid summer internships for Massachusetts college students who are under-resourced and often first-generation\, helping to bridge the opportunity gap for these promising young people. \nJoin us virtually to celebrate the 128 students who make up the Class of 2021. Hear about what they’ve worked on\, the lessons they’ve learned\, and the professional networks they’ve created to help them consider careers in the life sciences. \nWednesday\, August 18th at 12 pm via Zoom \nFinal agenda and login information to come.
URL:https://www.masslifesciences.com/event/project-onramp-showcase-2021/
LOCATION:Online\, online
ORGANIZER;CN="Project Onramp":MAILTO:lila@lifesciencecares.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210817T110000
DTEND;TZID=America/New_York:20210817T120000
DTSTAMP:20260413T083322
CREATED:20210802T155043Z
LAST-MODIFIED:20210802T155043Z
UID:14359-1629198000-1629201600@www.masslifesciences.com
SUMMARY:Rare Disease Research in the United States: Understanding FDA Guidance and Flexibility in the Application of Regulatory Standards
DESCRIPTION:The Orphan Drug Act (ODA) defines a rare disease as a disease or condition that affects less than 200\,000 people in the United States.  Within this range we see conditions like sickle cell disease with a prevalence of over 100\,000\, down to rare genetic diseases that may occur in a handful of patients. As approaches to clinical development are constrained by issues of enrollment and statistical powering\, the categories defined by prevalence distribution (rare\, ultra-rare and uber-rare) require differing approaches within the framework of identical statutory standards for safety and efficacy. At the level of the ultra and uber-rare conditions that make up the majority of rare disease\, there is an unmet need not only for treatments but also for the tools to evaluate whether a given treatment works.\nThis webinar will focus on challenges and areas of flexibility within the application of the statutory standards as they apply to rare diseases. Particular attention will be paid not only to the laws and guidelines that specifically relate to orphan drugs but also how the general regulatory standards that govern safety and efficacy are uniquely applied to rare diseases at different levels of prevalence. \nThis webinar will cover rare disease research: \nCore challenges – knowledge of the disease\, clinical trial design and enrollment and others\nThe legal framework and guidance relevant to rare disease research with case studies focusing on the role of innovative clinical trial design\, Expanded Access data\, and the natural history studies in recent approvals\nStrategies specific to ultra- and uber-rare diseases
URL:https://www.masslifesciences.com/event/rare-disease-research-in-the-united-states-understanding-fda-guidance-and-flexibility-in-the-application-of-regulatory-standards/
LOCATION:Online\, online
ORGANIZER;CN="MMS Holdings":MAILTO:media@mmsholdings.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210802T080000
DTEND;TZID=America/New_York:20210917T230000
DTSTAMP:20260413T083322
CREATED:20210621T195946Z
LAST-MODIFIED:20210621T200047Z
UID:14102-1627891200-1631919600@www.masslifesciences.com
SUMMARY:Foundations in Quality for the Life Sciences
DESCRIPTION:Quality is critically important to the success of Life Sciences companies. The Foundations in Quality for the Life Sciences Industry provides presents concepts\, tools and techniques for real world\, on‐the‐job application of quality that is practical for a wide range of organizations. It is targeted for the application of quality in life sciences\, including\, but not limited to: biotechnology\, pharmaceuticals\, biomedical\ntechnologies\, life systems technologies\, nutraceuticals\, cosmeceuticals\, food processing\, environmental\, biomedical devices\, and organizations and institutions that devote the majority of their efforts in the various stages of research\, development\, clinical trials\, manufacturing\, supply chain management\, project management\, technology transfer and commercialization. \nThis course provides an insight into the mindset of Quality along with an overview the concepts\, principles and processes/activities involved in Quality Assurance\, Quality Control\, and Regulatory Compliance within the Life Sciences Industry. Emphasis will be placed on understanding the “business of Biotech; the remit of Global Regulatory Agencies and principles/processes for establishing and enforcing regulation and guidance; Quality management systems\, operations and compliance; Quality leadership; Quality Planning; and Careers in the Quality profession. Students will be exposed to a variety of industry experts during the course. Emphasis will also be placed on current Good Manufacturing Practices\, Good Laboratory Practices and Good Clinical Practices. Students will gain a practical knowledge of Quality as a scientific discipline.
URL:https://www.masslifesciences.com/event/foundations-in-quality-for-the-life-sciences-2/
LOCATION:Online\, online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210728T160000
DTEND;TZID=America/New_York:20210728T190000
DTSTAMP:20260413T083322
CREATED:20210719T135537Z
LAST-MODIFIED:20210719T135537Z
UID:14303-1627488000-1627498800@www.masslifesciences.com
SUMMARY:Virtual BioXchange
DESCRIPTION:Miss being able to network with colleagues in the life science industry? We have you covered with the best virtual networking experience through Grapevine Network’s networking platform. Connect with life science colleagues from all over the world. \nBioXchange has gone virtual to allow the best online opportunity to interact with individuals from throughout the life science industry. The event will be hosted on Grapevine Network’s platform which provides an amazing experience that allows attendees the freedom to navigate between different group discussions within an interactive chatroom environment. The platform provides the closest experience to a live networking experience. \nParticipants are welcome to join the event at any point of time. The event is subject to run later than the posted end time as the room will stay open as long as people are actively engaged within the chat room. \n***Event is expected to sell out and NOT ALL RVSPS ARE GUARANTEED ENTRY into the event due to the limited attendee capacity offered on the platform.
URL:https://www.masslifesciences.com/event/virtual-bioxchange-4/
LOCATION:Online\, online
ORGANIZER;CN="BioXchange":MAILTO:bioxchange.boston@gmail.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210728T100000
DTEND;TZID=America/New_York:20210728T110000
DTSTAMP:20260413T083322
CREATED:20210713T123546Z
LAST-MODIFIED:20210713T123546Z
UID:14216-1627466400-1627470000@www.masslifesciences.com
SUMMARY:What can AI learn from our own brains? Bridging the gap between biology and code
DESCRIPTION:AI grows ever more powerful and ubiquitous\, powered by vast sources of data and inexpensive cloud processing power. Yet the human brain\, using just 25W of power and 6 kHz neuron speed\, remains many orders more efficient than current AI processing approaches. Leveraging insights from new optical and physiological recording techniques\, Prof. Bart M. ter Haar Romeny will help bridge the gap between AI and how the human brain processes sight\, giving practical applications with respect to computer vision and machine learning\, especially in medical image analysis such as neuroimaging that can help accelerate neurology research\, clinical trials and care delivery. \nA 30 minute lecture by Em.Prof. Romeny will be followed by a chat with his former students\, Vesna Prčkovska\, CEO\, and Paulo Rodriguez\, CTO of QMENTA. Please bring your questions for our closing Q&A. Zoom space is limited\, so reserve your place today. \nKey Takeaways:\n– How we can bridge the gap between biological and AI communities\n– New optical and physiological recording techniques in imaging analysis\n– Practical applications with respect to computer vision and machine learning \nProf. Bart M. ter Haar Romeny is emeritus professor in Biomedical Image Analysis at Eindhoven University of Technology in the Netherlands. He obtained his MSc in Applied Physics from Delft University of Technology and PhD from Utrecht University. \nHe worked his whole career on biologically inspired medical image analysis algorithms\, especially for computer-aided diagnosis (cancer\, heart\, brain\, diabetes)\, image guided neurosurgery and visualization of brain connectivity from MRI diffusion tensor imaging. He initiated and led the RetinaCheck project\, a large international AI-based retinal image screening program for diabetes. He published over 250 papers\, 12 books and book chapters\, and 3 patents. He teaches a national PhD course on the neuro-mathematics of deep learning and human visual perception.
URL:https://www.masslifesciences.com/event/what-can-ai-learn-from-our-own-brains-bridging-the-gap-between-biology-and-code/
LOCATION:Online\, online
ORGANIZER;CN="QMENTA":MAILTO:info@qmenta.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210727T170000
DTEND;TZID=America/New_York:20210807T170000
DTSTAMP:20260413T083322
CREATED:20210713T123813Z
LAST-MODIFIED:20210713T123837Z
UID:14213-1627405200-1628355600@www.masslifesciences.com
SUMMARY:Open Enrollment Program Leading Digital Transformation in Health Care
DESCRIPTION:This Harvard Medical School online program provides you with the knowledge\, tools and strategies to design and implement technology-enabled change initiatives in health care. It will feature a combination of live virtual class sessions and self-paced learning and discussions. A certificate of completion will be provided.
URL:https://www.masslifesciences.com/event/open-enrollment-program-leading-digital-transformation-in-health-care/
LOCATION:Virtual
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210722T160000
DTEND;TZID=America/New_York:20210722T180000
DTSTAMP:20260413T083322
CREATED:20210527T143823Z
LAST-MODIFIED:20210527T143823Z
UID:13974-1626969600-1626976800@www.masslifesciences.com
SUMMARY:The Big Pitch VIRTUAL COMPETITION
DESCRIPTION:The Big Pitch is a virtual quick pitch competition for the most promising biotech startups in the US. This series challenges all-stars from 3 regions—West\, South and Northeast—to score points with investor judges for their treatment\, technology or therapy. The winning startup from each region will win the grand prize and bragging rights. \nFeatures the top life science startups from the West\, South and Northeast regions in the US\nStartups apply and two entrepreneurs per region will be selected by an advisory board\nSeven-minute live pitches followed by a 5 min Q&A with VC judges\nWinners are selected by a panel of investors and the LaunchBio community
URL:https://www.masslifesciences.com/event/the-big-pitch-virtual-competition/
LOCATION:Online\, online
ORGANIZER;CN="LaunchBio":MAILTO:joan@launchbio.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210722T083000
DTEND;TZID=America/New_York:20210722T153000
DTSTAMP:20260413T083322
CREATED:20210621T200527Z
LAST-MODIFIED:20210621T200635Z
UID:14031-1626942600-1626967800@www.masslifesciences.com
SUMMARY:MALSI+2021 The Hub at Warp Speed: From Lab to Jab to Beyond
DESCRIPTION:The 14th Annual Massachusetts Life Sciences Innovation (MALSI+) Day is the biggest day for life sciences startups and innovation in the Commonwealth. MALSI+ 2021 is a hands-on event which brings together scientists\, post-docs\, professors\, entrepreneurs\, innovators\, and venture capitalists. The event features a keynote by Barbara Fox\, CEO of Rheos Medicines; pharmaceutical innovation and investor perspective panels; an innovators’ marketplace; poster competition with prizes; 1:1 curated connections and networking on the Goldcast platform. The day is filled with networking opportunities. Don’t miss it!
URL:https://www.masslifesciences.com/event/malsi2021-the-hub-at-warp-speed-from-lab-to-jab-to-beyond/
LOCATION:Online\, online
ORGANIZER;CN="MassVentures":MAILTO:mwilcox@mass-ventures.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210715T120000
DTEND;TZID=America/New_York:20210715T130000
DTSTAMP:20260413T083322
CREATED:20210621T200123Z
LAST-MODIFIED:20210621T200123Z
UID:14090-1626350400-1626354000@www.masslifesciences.com
SUMMARY:How to Tell Your Innovation's Amazing Story
DESCRIPTION:How can you cut through the noise and help potential partners and investors understand what makes your product special\, innovative\, and worth a closer look? \nInvestors\, journalists\, and the general public are awash in information overload. Join Joshua Gunn\, founder of Cambridge\, MA-based creative studio Planet Nutshell\, for a session on how you can easily use the power of video to explain what you do and amplify the message of your company or idea. \nIt’s all about your story.\nWe see it in the most compelling\, successful pitches at M2D2 events like Barracuda Bowl and the $200K Challenge: It’s the personal stories behind the innovations that make potential investors and strategic partners prick up their ears and want to learn more. Tell your story on video and suddenly it becomes visually captivating\, more memorable\, and highly sharable. \nJosh will reveal insights from more than a decade of working with biotech and healthcare companies of all sizes\, from fledgling startups to big corporations. We’ll explore the one thing that holds true for all of them: The importance and power of telling a great story.
URL:https://www.masslifesciences.com/event/how-to-tell-your-innovations-amazing-story/
LOCATION:Online\, online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210712T120000
DTEND;TZID=America/New_York:20210712T123000
DTSTAMP:20260413T083322
CREATED:20210621T201119Z
LAST-MODIFIED:20210621T201119Z
UID:14002-1626091200-1626093000@www.masslifesciences.com
SUMMARY:Clinical Trials: Patients as Research Partners
DESCRIPTION:In this Harvard Medical School special event\, Linnea Olson\, a patient advocate\, activist\, blogger and artist\, will share her remarkable journey as a participant in six phase I clinical trials for ALK-mutant non-small cell lung cancer (NSCLC) – three of which led to FDA approval of new targeted therapies. Linnea will be joined by two senior drug development leaders whose therapies have played such an important part in her story. Join us for a wide-ranging discussion on patient-centric drug discovery and development\, exciting advances in cancer treatments\, and living with cancer.
URL:https://www.masslifesciences.com/event/clinical-trials-patients-as-research-partners/
LOCATION:Online\, online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210630T090000
DTEND;TZID=America/New_York:20210630T113000
DTSTAMP:20260413T083322
CREATED:20210621T200554Z
LAST-MODIFIED:20210621T200727Z
UID:14015-1625043600-1625052600@www.masslifesciences.com
SUMMARY:Neuroimmunology: Potential for Novel Therapeutics for CNS Disorders
DESCRIPTION:On June 30th \, Johnson & Johnson Innovation will host a virtual scientific event on state-of-the-art developments in neuroimmunology\, bringing together entrepreneurs\, start-ups\, researchers\, and scientists from across Europe and beyond. Learn more and register today
URL:https://www.masslifesciences.com/event/neuroimmunology-potential-for-novel-therapeutics-for-cns-disorders/
LOCATION:Online\, online
ORGANIZER;CN="Johnson & Johnson Innovation":MAILTO:clee22@its.jnj.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210624T123000
DTEND;TZID=America/New_York:20210624T133000
DTSTAMP:20260413T083322
CREATED:20210621T200314Z
LAST-MODIFIED:20210621T200344Z
UID:14049-1624537800-1624541400@www.masslifesciences.com
SUMMARY:BARDA Mask Innovation Challenge Awards Ceremony
DESCRIPTION:The Biomedical Advanced Research & Development Authority’s Division of Research\, Innovation\, & Ventures (BARDA DRIVe)\, in partnership with the National Institute for Occupational Safety and Health (NIOSH)\, is proud to present the Awards Ceremony for the “Mask Innovation Challenge: Building Tomorrow’s Mask.” \nThis event will celebrate our 10 Phase 1 finalist teams. They’ve all been working tirelessly to answer the PPE challenge of the pandemic era: Re-imagining and creating the mask of the future. \nWe are proud to announce these winners and highlight our partners and supporters in BARDA’s first-ever Challenge Competition. See you there!
URL:https://www.masslifesciences.com/event/barda-mask-innovation-challenge-awards-ceremony/
LOCATION:Online\, online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210623T160000
DTEND;TZID=America/New_York:20210623T190000
DTSTAMP:20260413T083322
CREATED:20210621T200258Z
LAST-MODIFIED:20210621T200258Z
UID:14050-1624464000-1624474800@www.masslifesciences.com
SUMMARY:Venture Capital 101
DESCRIPTION:If you are interested in learning more about how VC investing works\, what their process is for engaging with a life science startup\, and how they manage their portfolios; then you will not want to miss our next event. Please join us on June 23rd from 4-5PM EDT for a talk with Riley Rodgers from Valia Ventures as he explains the ins and outs of VC investing followed by open networking from 5-7PM EDT via the Grapevine Network. \nParticipants are welcome to join the event at any point of time. The event is subject to run later than the posted end time as the room will stay open as long as people are actively engaged within the chat room. \n***Event is expected to sell out and NOT ALL RVSPS ARE GUARANTEED ENTRY into the event due to the limited attendee capacity offered on the platform.
URL:https://www.masslifesciences.com/event/venture-capital-101/
LOCATION:Online\, online
ORGANIZER;CN="BioXchange":MAILTO:bioxchange.boston@gmail.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210623T110000
DTEND;TZID=America/New_York:20210623T120000
DTSTAMP:20260413T083322
CREATED:20210621T200807Z
LAST-MODIFIED:20210621T200807Z
UID:14014-1624446000-1624449600@www.masslifesciences.com
SUMMARY:The Entrepreneurial Way: Veterans Lead in Business & Beyond
DESCRIPTION:Join Johnson & Johnson Innovation on June 23rd for a conversation with leaders from the Johnson & Johnson Family of Companies\, Bunker Labs\, and other experts in the field to discuss the state of Veteran entrepreneurship and the potential impact on healthcare and beyond. \nWe’ll also share details about the Veterans Lead QuickFire Challenge series which is offering grant funding and mentorship opportunities for Veteran entrepreneurs in health care.
URL:https://www.masslifesciences.com/event/the-entrepreneurial-way-veterans-lead-in-business-beyond/
LOCATION:Virtual Event
ORGANIZER;CN="Johnson & Johnson Innovation":MAILTO:clee22@its.jnj.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210622T110000
DTEND;TZID=America/New_York:20210622T123000
DTSTAMP:20260413T083322
CREATED:20210621T200823Z
LAST-MODIFIED:20210621T200823Z
UID:14013-1624359600-1624365000@www.masslifesciences.com
SUMMARY:Digital Therapeutics and the Future of Medicine
DESCRIPTION:With healthcare becoming more digital\, especially over the past year\, innovators are continuing to demonstrate the power of these potential solutions. However\, despite the constant growth in the last decade and the surge in innovations in the past year\, there are still significant challenges in the path to success for these solutions. \nJoin Johnson & Johnson Innovation – JLABS on June 22nd as they welcome experts in the space to discuss the opportunities and challenges of potential digital solutions from a variety of perspectives\, and how large players in the ecosystem are looking towards the future.
URL:https://www.masslifesciences.com/event/digital-therapeutics-and-the-future-of-medicine/
LOCATION:Online\, online
ORGANIZER;CN="Johnson & Johnson Innovation":MAILTO:clee22@its.jnj.com
END:VEVENT
END:VCALENDAR